Explore how viral vector CDMOs improve late-stage cell and gene therapy success by reducing risk, variability, and complexity. The post Viral vector production: How CDMOs influence late-stage development success appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit i